{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:06:17Z","timestamp":1792026377552,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025780"],"award-info":[{"award-number":["AI025780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102618"],"award-info":[{"award-number":["AI102618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125045"],"award-info":[{"award-number":["AI125045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI139615"],"award-info":[{"award-number":["AI139615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["contract 75N93019C00064"],"award-info":[{"award-number":["contract 75N93019C00064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["contract 75N93019C00064"],"award-info":[{"award-number":["contract 75N93019C00064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI139615"],"award-info":[{"award-number":["AI139615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI095213"],"award-info":[{"award-number":["AI095213"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172154"],"award-info":[{"award-number":["AI172154"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025780"],"award-info":[{"award-number":["AI025780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025780"],"award-info":[{"award-number":["AI025780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025780"],"award-info":[{"award-number":["AI025780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025780"],"award-info":[{"award-number":["AI025780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125045"],"award-info":[{"award-number":["AI125045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI025045"],"award-info":[{"award-number":["AI025045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["contract 75N93019C00064"],"award-info":[{"award-number":["contract 75N93019C00064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI072195"],"award-info":[{"award-number":["AI072195"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vaccination with glucan particles (GP) containing the\n                    <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                    chitin deacetylases Cda1 and Cda2 protect mice against experimental cryptococcosis. Here, immunological correlates of vaccine-mediated protection were explored. Studies comparing knockout and wild-type mice demonstrated CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells are crucial, while B cells and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells are dispensable. Protection was abolished following CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell depletion during either vaccination or infection but was retained if CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells were only partially depleted. Vaccination elicited systemic and durable antigen-specific immune responses in peripheral blood mononuclear cells (PBMCs), spleens, and lungs. Following vaccination and fungal challenge, robust T-helper (Th) 1 and Th17 responses were observed in the lungs. Protection was abrogated in mice congenitally deficient in interferon (IFN) \u03b3, IFN\u03b3 receptor, interleukin (IL)-1\u03b2, IL-6, or IL-23. Thus, CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and specific proinflammatory cytokines are required for GP-vaccine-mediated protection. Importantly, retention of protection in the setting of partial CD4\n                    <jats:sup>+<\/jats:sup>\n                    T depletion suggests a pathway for vaccinating at-risk immunocompromised individuals.\n                  <\/jats:p>","DOI":"10.1038\/s41541-023-00606-0","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T01:03:33Z","timestamp":1675299813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-4582","authenticated-orcid":false,"given":"Ruiying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-0076","authenticated-orcid":false,"given":"Lorena V. N.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrono K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2680-4854","authenticated-orcid":false,"given":"Maureen M.","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5749-3112","authenticated-orcid":false,"given":"Charles A.","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3799-3064","authenticated-orcid":false,"given":"Stuart M.","family":"Levitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"606_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","volume":"14","author":"RC May","year":"2016","unstructured":"May, R. C., Stone, N. R., Wiesner, D. L., Bicanic, T. & Nielsen, K. Cryptococcus: from environmental saprophyte to global pathogen. Nat. Rev. Microbiol. 14, 106\u2013117 (2016).","journal-title":"Nat. Rev. Microbiol"},{"key":"606_CR2","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S1473-3099(20)30771-4","volume":"21","author":"KE Stott","year":"2021","unstructured":"Stott, K. E. et al. Cryptococcal meningoencephalitis: time for action. Lancet Infect. Dis. 21, e259\u2013e271 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"606_CR3","doi-asserted-by":"publisher","unstructured":"Rajasingham, R. et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00499-6 (2022).","DOI":"10.1016\/S1473-3099(22)00499-6"},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","volume":"19","author":"KR Iyer","year":"2021","unstructured":"Iyer, K. R., Revie, N. M., Fu, C., Robbins, N. & Cowen, L. E. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat. Rev. Microbiol. 19, 454\u2013466 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"606_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00294-8","volume":"6","author":"LVN Oliveira","year":"2021","unstructured":"Oliveira, L. V. N., Wang, R., Specht, C. A. & Levitz, S. M. Vaccines for human fungal diseases: close but still a long way to go. NPJ Vaccines 6, 33 (2021).","journal-title":"NPJ Vaccines"},{"key":"606_CR6","doi-asserted-by":"publisher","first-page":"02145","DOI":"10.1128\/mBio.02145-19","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Wang, K., Masso-Silva, J. A., Rivera, A. & Xue, C. A heat-killed cryptococcus mutant strain induces host protection against multiple invasive mycoses in a murine vaccine model. mBio 10, 02145 (2019).","journal-title":"mBio"},{"key":"606_CR7","doi-asserted-by":"publisher","first-page":"e02909","DOI":"10.1128\/mBio.02909-18","volume":"10","author":"AC Colombo","year":"2019","unstructured":"Colombo, A. C. et al. Cryptococcus neoformans glucuronoxylomannan and sterylglucoside are required for host protection in an animal vaccination model. mBio 10, e02909\u2013e02918 (2019).","journal-title":"mBio"},{"key":"606_CR8","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1128\/mBio.00547-16","volume":"7","author":"R Upadhya","year":"2016","unstructured":"Upadhya, R. et al. Induction of protective immunity to cryptococcal infection in mice by a heat-killed, chitosan-deficient strain of Cryptococcus neoformans. mBio 7, e00547\u201300516 (2016).","journal-title":"mBio"},{"key":"606_CR9","doi-asserted-by":"crossref","unstructured":"Ueno, K., Yanagihara, N., Shimizu, K. & Miyazaki, Y. Vaccines and protective immune memory against Cryptococcosis. Biol. Pharm. Bull. 43, 230-239 (2020).","DOI":"10.1248\/bpb.b19-00841"},{"key":"606_CR10","doi-asserted-by":"publisher","first-page":"e01433","DOI":"10.1128\/mBio.01433-15","volume":"6","author":"B Zhai","year":"2015","unstructured":"Zhai, B. et al. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio 6, e01433\u201301415 (2015).","journal-title":"mBio"},{"key":"606_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1128\/IAI.00274-06","volume":"75","author":"FL Wormley Jr.","year":"2007","unstructured":"Wormley, F. L. Jr., Perfect, J. R., Steele, C. & Cox, G. M. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect. Immun. 75, 1453\u20131462 (2007).","journal-title":"Infect. Immun."},{"key":"606_CR12","first-page":"1","volume":"8","author":"MCC Van Dyke","year":"2017","unstructured":"Van Dyke, M. C. C. et al. Induction of broad-spectrum protective immunity against disparate Cryptococcus serotypes. Front. Immunol. 8, 1\u201316 (2017).","journal-title":"Front. Immunol."},{"key":"606_CR13","doi-asserted-by":"publisher","first-page":"100066","DOI":"10.1016\/j.tcsw.2021.100066","volume":"7","author":"R Upadhya","year":"2021","unstructured":"Upadhya, R. et al. Cryptococcus neoformans Cda1 and Cda2 coordinate deacetylation of chitin during infection to control fungal virulence. Cell Surf. 7, 100066 (2021).","journal-title":"Cell Surf."},{"key":"606_CR14","doi-asserted-by":"publisher","first-page":"e01872","DOI":"10.1128\/mBio.01872-17","volume":"8","author":"CA Specht","year":"2017","unstructured":"Specht, C. A. et al. Vaccination with recombinant cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and cryptococcal species. MBio 8, e01872\u201317 (2017).","journal-title":"MBio"},{"key":"606_CR15","doi-asserted-by":"publisher","first-page":"e0336721","DOI":"10.1128\/mbio.03367-21","volume":"13","author":"CA Specht","year":"2022","unstructured":"Specht, C. A. et al. Protection of mice against experimental cryptococcosis by synthesized peptides delivered in glucan particles. mBio 13, e0336721 (2022).","journal-title":"mBio"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.vaccine.2019.10.051","volume":"38","author":"MM Hester","year":"2020","unstructured":"Hester, M. M. et al. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens. Vaccine 38, 620\u2013626 (2020).","journal-title":"Vaccine"},{"key":"606_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/350423a0","volume":"350","author":"D Kitamura","year":"1991","unstructured":"Kitamura, D., Roes, J., K\u00fchn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423\u2013426 (1991).","journal-title":"Nature"},{"key":"606_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","volume":"5","author":"J Chen","year":"1993","unstructured":"Chen, J. et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5, 647\u2013656 (1993).","journal-title":"Int. Immunol."},{"key":"606_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","volume":"36","author":"MS Lionakis","year":"2018","unstructured":"Lionakis, M. S. & Levitz, S. M. Host control of fungal infections: lessons from basic studies and human cohorts. Annu. Rev. Immunol. 36, 157\u2013191 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"606_CR20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S2352-3018(22)00067-4","volume":"9","author":"JS Lee","year":"2022","unstructured":"Lee, J. S. et al. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV 9, S2 (2022).","journal-title":"Lancet HIV"},{"key":"606_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/jof3040064","volume":"3","author":"L Mukaremera","year":"2017","unstructured":"Mukaremera, L. & Nielsen, K. Adaptive immunity to Cryptococcus neoformans infections. J. Fungi 3, 64 (2017).","journal-title":"J. Fungi"},{"key":"606_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","volume":"26","author":"JN Jarvis","year":"2012","unstructured":"Jarvis, J. N. et al. Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 26, 1105\u20131113 (2012).","journal-title":"AIDS"},{"key":"606_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"Williamson, P. R. et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat. Rev. Neurol. 13, 13\u201324 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"606_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/cid\/cix867","volume":"66","author":"IA George","year":"2018","unstructured":"George, I. A., Spec, A., Powderly, W. G. & Santos, C. A. Q. Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated cryptococcosis: a population-based study. Clin. Infect. Dis. 66, 608\u2013611 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1086\/599318","volume":"200","author":"K Subramaniam","year":"2009","unstructured":"Subramaniam, K. et al. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J. Infect. Dis. 200, 244\u2013251 (2009).","journal-title":"J. Infect. Dis."},{"key":"606_CR26","doi-asserted-by":"publisher","first-page":"7920","DOI":"10.4049\/jimmunol.174.12.7920","volume":"174","author":"DM Lindell","year":"2005","unstructured":"Lindell, D. M., Moore, T. A., McDonald, R. A., Toews, G. B. & Huffnagle, G. B. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J. Immunol. 174, 7920\u20137928 (2005).","journal-title":"J. Immunol."},{"key":"606_CR27","doi-asserted-by":"publisher","first-page":"e00573","DOI":"10.1128\/mBio.00573-13","volume":"4","author":"S Rohatgi","year":"2013","unstructured":"Rohatgi, S. et al. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease. mBio 4, e00573\u201300513 (2013).","journal-title":"mBio"},{"key":"606_CR28","doi-asserted-by":"publisher","first-page":"e00265","DOI":"10.1128\/mBio.00265-13","volume":"4","author":"WA Szymczak","year":"2013","unstructured":"Szymczak, W. A. et al. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans infection. mBio 4, e00265\u201313 (2013).","journal-title":"mBio"},{"key":"606_CR29","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1128\/iai.60.11.4534-4541.1992","volume":"60","author":"J Mukherjee","year":"1992","unstructured":"Mukherjee, J., Scharff, M. D. & Casadevall, A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60, 4534\u20134541 (1992).","journal-title":"Infect. Immun."},{"key":"606_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","volume":"14","author":"SJ Devi","year":"1996","unstructured":"Devi, S. J. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine 14, 841\u2013844 (1996).","journal-title":"Vaccine"},{"key":"606_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1128\/CVI.00130-08","volume":"15","author":"K Datta","year":"2008","unstructured":"Datta, K., Lees, A. & Pirofski, L. A. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clin. Vaccin. Immunol. 15, 1176\u20131187 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"606_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1128\/iai.65.2.525-530.1997","volume":"65","author":"KM Aguirre","year":"1997","unstructured":"Aguirre, K. M. & Johnson, L. L. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect. Immun. 65, 525\u2013530 (1997).","journal-title":"Infect. Immun."},{"key":"606_CR33","doi-asserted-by":"publisher","first-page":"e6854","DOI":"10.1371\/journal.pone.0006854","volume":"4","author":"KL Wozniak","year":"2009","unstructured":"Wozniak, K. L. et al. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE 4, e6854 (2009).","journal-title":"PLoS ONE"},{"key":"606_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1084\/jem.173.3.755","volume":"173","author":"JO Hill","year":"1991","unstructured":"Hill, J. O. & Harmsen, A. G. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med. 173, 755\u2013758 (1991).","journal-title":"J. Exp. Med"},{"key":"606_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.173.4.793","volume":"173","author":"GB Huffnagle","year":"1991","unstructured":"Huffnagle, G. B., Yates, J. L. & Lipscomb, M. F. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173, 793\u2013800 (1991).","journal-title":"J. Exp. Med"},{"key":"606_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jlb.55.1.35","volume":"55","author":"GB Huffnagle","year":"1994","unstructured":"Huffnagle, G. B., Lipscomb, M. F., Lovchik, J. A., Hoag, K. A. & Street, N. E. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol. 55, 35\u201342 (1994).","journal-title":"J. Leukoc. Biol."},{"key":"606_CR37","doi-asserted-by":"publisher","first-page":"e1002771","DOI":"10.1371\/journal.ppat.1002771","volume":"8","author":"SG Nanjappa","year":"2012","unstructured":"Nanjappa, S. G., Heninger, E., Wuthrich, M., Gasper, D. J. & Klein, B. S. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog. 8, e1002771 (2012).","journal-title":"PLoS Pathog."},{"key":"606_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/tri.12321","volume":"27","author":"M Fernandez-Ruiz","year":"2014","unstructured":"Fernandez-Ruiz, M. et al. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation. Transpl. Int. 27, 674\u2013685 (2014).","journal-title":"Transpl. Int."},{"key":"606_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","volume":"386","author":"JN Jarvis","year":"2022","unstructured":"Jarvis, J. N. et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N. Engl. J. Med. 386, 1109\u20131120 (2022).","journal-title":"N. Engl. J. Med."},{"key":"606_CR40","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1128\/JCM.37.10.3204-3209.1999","volume":"37","author":"D Garcia-Hermoso","year":"1999","unstructured":"Garcia-Hermoso, D., Janbon, G. & Dromer, F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J. Clin. Microbiol. 37, 3204\u20133209 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"606_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jinf.2018.06.016","volume":"77","author":"K Brunet","year":"2018","unstructured":"Brunet, K., Alanio, A., Lortholary, O. & Rammaert, B. Reactivation of dormant\/latent fungal infection. J. Infect. 77, 463\u2013468 (2018).","journal-title":"J. Infect."},{"key":"606_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","volume":"8","author":"A Cassone","year":"2008","unstructured":"Cassone, A. Fungal vaccines: real progress from real challenges. Lancet Infect. Dis. 8, 114\u2013124 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"606_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/mmy\/myu045","volume":"53","author":"DL Portuondo","year":"2015","unstructured":"Portuondo, D. L., Ferreira, L. S., Urbaczek, A. C., Batista-Duharte, A. & Carlos, I. Z. Adjuvants and delivery systems for antifungal vaccines: current state and future developments. Med. Mycol. 53, 69\u201389 (2015).","journal-title":"Med. Mycol."},{"key":"606_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2018.00651","volume":"9","author":"W Elsegeiny","year":"2018","unstructured":"Elsegeiny, W., Marr, K. A. & Williamson, P. R. Immunology of cryptococcal infections: developing a rational approach to patient therapy. Front. Immunol. 9, 651 (2018).","journal-title":"Front. Immunol."},{"key":"606_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/infdis\/jiv067","volume":"212","author":"JE Scriven","year":"2015","unstructured":"Scriven, J. E. et al. Early ART after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial. J. Infect. Dis. 212, 769\u2013778 (2015).","journal-title":"J. Infect. Dis."},{"key":"606_CR46","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2353\/ajpath.2009.090530","volume":"175","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175, 2489\u20132500 (2009).","journal-title":"Am. J. Pathol."},{"key":"606_CR47","doi-asserted-by":"publisher","first-page":"e00164","DOI":"10.1128\/mBio.00164-10","volume":"1","author":"H Huang","year":"2010","unstructured":"Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A. & Levitz, S. M. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. mBio 1, e00164\u201310 (2010).","journal-title":"mBio"},{"key":"606_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cei.13356","volume":"198","author":"A Abraham","year":"2019","unstructured":"Abraham, A., Ostroff, G., Levitz, S. M. & Oyston, P. C. F. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin. Exp. Immunol. 198, 143\u2013152 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"606_CR49","doi-asserted-by":"crossref","unstructured":"Deepe, G. S. Jr. et al. Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice. Vaccine 36, 3359\u20133367 (2018).","DOI":"10.1016\/j.vaccine.2018.04.047"},{"key":"606_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","volume":"9","author":"G Kak","year":"2018","unstructured":"Kak, G., Raza, M. & Tiwari, B. K. Interferon-gamma (IFN-gamma): exploring its implications in infectious diseases. Biomol. Concepts 9, 64\u201379 (2018).","journal-title":"Biomol. Concepts"},{"key":"606_CR51","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","volume":"17","author":"F De Benedetti","year":"2021","unstructured":"De Benedetti, F., Prencipe, G., Bracaglia, C., Marasco, E. & Grom, A. A. Targeting interferon-gamma in hyperinflammation: opportunities and challenges. Nat. Rev. Rheumatol. 17, 678\u2013691 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"606_CR52","doi-asserted-by":"publisher","first-page":"e1004843","DOI":"10.1371\/journal.ppat.1004843","volume":"11","author":"CM Leopold Wager","year":"2015","unstructured":"Leopold Wager, C. M. & Wormley, F. L. Jr. Is development of a vaccine against Cryptococcus neoformans feasible? PLoS Pathog. 11, e1004843 (2015).","journal-title":"PLoS Pathog."},{"key":"606_CR53","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.176.2.1098","volume":"176","author":"MA Kleinschek","year":"2006","unstructured":"Kleinschek, M. A. et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176, 1098\u20131106 (2006).","journal-title":"J. Immunol."},{"key":"606_CR54","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6, a016295 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"606_CR55","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"606_CR56","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1128\/IAI.69.10.6445-6455.2001","volume":"69","author":"DO Beenhouwer","year":"2001","unstructured":"Beenhouwer, D. O. et al. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect. Immun. 69, 6445\u20136455 (2001).","journal-title":"Infect. Immun."},{"key":"606_CR57","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1128\/iai.62.5.1975-1981.1994","volume":"62","author":"SM Levitz","year":"1994","unstructured":"Levitz, S. M., Tabuni, A., Kornfeld, H., Reardon, C. C. & Golenbock, D. T. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62, 1975\u20131981 (1994).","journal-title":"Infect. Immun."},{"key":"606_CR58","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.4049\/jimmunol.1500865","volume":"195","author":"M Chen","year":"2015","unstructured":"Chen, M. et al. Internalized Cryptococcus neoformans activates the canonical caspase-1 and the noncanonical caspase-8 inflammasomes. J. Immunol. 195, 4962\u20134972 (2015).","journal-title":"J. Immunol."},{"key":"606_CR59","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.4049\/jimmunol.172.5.2827","volume":"172","author":"N Ghilardi","year":"2004","unstructured":"Ghilardi, N. et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172, 2827\u20132833 (2004).","journal-title":"J. Immunol."},{"key":"606_CR60","doi-asserted-by":"publisher","first-page":"e1004261","DOI":"10.1371\/journal.pgen.1004261","volume":"10","author":"G Janbon","year":"2014","unstructured":"Janbon, G. et al. Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation. PLoS Genet. 10, e1004261 (2014).","journal-title":"PLoS Genet."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00606-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T04:05:41Z","timestamp":1675483541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00606-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00606-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}